Emerging modalities such as protein degraders, oral peptides and oligonucleotides are creating new bioanalytical challenges. Developing robust assays, validating methods and generating trusted data quickly are critical to keeping IND-enabling programs on track.
Veloxity Labs specializes in supporting complex and fast-moving therapeutic programs with high-quality LC-MS bioanalysis, rapid study startup and scientifically rigorous method development. Whether you’re preparing for an IND or advancing novel therapeutic modalities, our team helps generate the data needed to move forward with confidence.
Why Meet with Veloxity?
Let’s discuss how we can support your program with:
- Oral peptides and other complex therapeutic modalities
- Advanced LC-MS and HRMS capabilities
- Rapid study startup and responsive project support
- GLP method development and validation
- Trusted bioanalytical data for IND-enabling studies
Meeting at PBSS Boston?
Connect with Shelly Robbins during the workshop.
